Summary
A total of 364 schizophrenic outpatients who were stabilized for 3 months on continuous neuroleptic therapy after discharge from the hospital were rated according to three different scales for depressive syndromes (Brief Psychiatric Rating Scale anxious depression factor, AMDP/depression, and the self-rating PD-S depression scale). Between 19.5% and 27.5% of the patients were rated as depressed, or 35.7%–42.8%, when mild depressive syndromes were included. There were low, but significant correlations between demographic or life-event data and depression scores on the self-rating scale, whereas fewer correlations were found on the observer ratings. No associations were found between social adjustment and depression. Moderate correlations were found between measures of the apathetic syndrome and depression ratings, while observer ratings showed higher correlations than the self-rating. High depression scores, especially in the observer ratings, correlated with scales for global psychopathological assessment (CGI, GAS). There were significant correlations between extrapyramidal rigidity and observer rating depression scores, whereas the total amount of neuroleptics given had no influence. These results are interpreted on the basis of hypotheses about depressive syndromes in schizophrenia.
Similar content being viewed by others
References
Allebeck P, Varia A, Kristjansson E, Wistedt B (1987) Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand 76:414–419
Barnes TRE, Curson DA, Liddle PF, Patel M (1989) The nature and prevalence of depression in chronic schizophrenic in patients. Br J Psychiatry 154:486–491
Bartels SJ, Drake RE (1988) Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 29:467–483
Becker RE (1970) Evaluation of an amitriptyline-perphenazine combination in chronic schizophrenia. Am J Psychiatry 127:827–831
Becker RE (1983) Implications of the efficacy of thiotixene and a chlorpromazine-imipramine combination for depression in schizophrenia. Am J Psychiatry 140:208–211
Becker RE, Colliver JA, Verhulst SJ (1985) Diagnosis of secondary depression in schizophrenia. J Clin Psychiatry 46:9–13
Becker RE, Singh MM, Meisler N, Shillcut S (1985) Clinical significance, evaluation, and management of secondary depression in schizophrenia. J Clin Psychiatry 46:26–32
Berrios GE, Bulbena A (1987) Post psychotic depression: the Fulbourn cohort. Acta Psychiatr Scand 76:89–93
Black DW, Winokur G, Warrack G (1985) Suicide in schizophrenia: the Iowa Record Linkage Study. J Clin Psychiatry 46:14–17
Bleuler E (1911) Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg B (ed) Handbuch der Psychiatrie. Deuticke, Leipzig, pp 172–173
Conrad K (1987) Die beginnende Schizophrenie. Thieme, Stuttgart, p 81
Craig TJ, Natta P van (1976) Recognition of depressed affect in hospitalized psychiatric patients: staff and patient preceptions. Dis Nerv Syst 37:561–566
Donlon PT, Rada RT, Arora KK (1976) Depression and the reintegration of acute schizophrenia. Am J Psychiatry 133: 1265–1268
Drake RE, Cotton PG (1986) Depression, hopelessness and suicide in chronic schizophrenia. Br J Psychiatry 148:554–559
Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766–771
Fähndrich E (1982) Schlafentzug-Behandlung depressiver Syndrome bei schizophrener Grunderkrankung. Nervenarzt 53:279–283
Galdi J, Reider RO, Silber D, Bonato RR (1981) Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study. Psychol Med 11:713–728
Gebhardt R, Pietzcker A, Strauss A, Stoeckel M, Langer C, Freudenthal K (1983) Skalenbildung im AMDP-System. Arch Psychiatr Nervenkr 233:223–245
Goplerud E, Depue RA (1978) The diagnostic ambiguity of postpsychotic depression. Schizophr Bull 4:477–479
Guy W, Ban TA (1982) AMPD-System. Manual for the assessment and documentation of psychopathology. Springer, Berlin Heidelberg New York
Häfner H (1989) Ist Schizophrenie eine Krankheit? Epidemiologische Daten und spekulative Folgerungen. Nervenarzt 60:191–199
Heinrich K (1960) Die gezielte Symptomprovokation mit monoaminooxidasehemmenden Substanzen in Diagnostik und Therapie schizophrener Psychosen. Nervenarzt 31:507
Heinrich K (1967) Zur Bedeutung des postremissiven Erschöpfungs-Syndroms für die Rehabilitation Schizophrener. Nervenarzt 38:487–491
Helmchen H, Hippius H (1967) Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt 38:455–458
Hirsch SR (1982) Comments. Depression ‘revealed’ in schizophrenia. Br J Psychiatry 142:421–423
Hogarty GE, Munetz MR (1984) Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate. J Clin Pharmacol 4:17–24
House A, Bostock J, Cooper U (1987) Depressive syndromes in the year following onset of a first schizophrenic illness. Br J Psychiatry 151:773–779
Jeste DV, Karson CN, Wyatt RJ (1984) Movement disorders and psychopathology. In: Jeste DV, Wyatt RJ (eds) Neuropsychiatric movement disorders. American Psychiatric Publications, Washington, D.C.
Johnson DAW (1981) Depression in schizophrenia: some observations in prevalence, etiology, and treatment. Acta Psychiatr Scand [Suppl.] 63:291
Johnson DAW (1981) Studies of depressive symptoms in schizophrenia. II. A two-year longitudinal study of symptoms. Br J Psychiatry 139:93–96
Johnson DAW (1981) Studies of depressive symptoms in schizophrenia. III. A double-blind trial of orphenadrine against placebo. Br J Psychiatry 139:96–97
Knights A, Hirsch SR (1981) ‘Revealed’ depression and drug treatment for schizophrenia. Arch Gen Psychiatry 38:806–811
Kraepelin E (1913) Psychiatrie, vol III, part II, 3rd edn. Abel, Leipzig
Kramer MS, Vogel WH, DiJohnson C, Dewey DA, Sheves P, Cavicchia S, Litle P, Schmidt P, Kimes I (1989) Antidepressants in ‘depressed’ schizophrenic inpatients. Arch Gen Psychiatry 46:922–928
Mandel MR, Severe JB, Schooler NR, Gelenberg AJ, Mieske M (1982) Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 39:197–203
Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment and Parkinson disease. Neurology 31:645–650
McGlashan TH (1982) Aphanisis: the syndrome of pseudodepression in chronic schizophrenia. Schizophr Bull 8:118–134
McGlashan TH, Carpenter WT (1976) An investigation of the postpsychotic depressive syndrome. Am J Psychiatry 133:14–19
Miles CP (1977) Conditions predisposing to suicide: a review. J Nerv Ment Dis 164:275–280
Möller HD, Zerssen D von (1981) Depressive Symptomatik im stationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmakopsychiatrie 14:172–179
Möller HJ, Zerssen D von (1982) Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull 8:109–117
Möller HJ, Zerssen D von (1986) Depression in schizophrenia. In: Burrows GD, Norman TR, Rubinstein G (eds) Handbook of studies on schizophrenia, part I. Elsevier, Amsterdam, pp 183–191
Müller P (1981) Depressive Syndrome im Verlauf schizophrener Erkrankungen. Enke, Stuttgart
Müller P (1990) Neuroleptika-induzierte Depressionen — Tatsache oder Fiktion? In: Heinrich K (ed) Leitlinien neuroleptischer Therapie. Springer, Berlin
NIMH — National Institute of Mental Health (1976) 028 CGI. Clinical Global Impressions. In: Guy W, Bonato RR (eds) ECDEU assessment manual for psychopharmacology. Rev Ed, Rockville, Maryland, pp 217–222
Overall JE, Gorham DR (1976) 047 BPRS. Brief Psychiatric Rating Scale. In: Guy W (ed) ECDEU assessment manual for psychopharmacology. Rev Ed, Rockville, Maryland, pp 157–169
Overall JE, Hollister LE, Pichot P (1967) Major psychiatric disorders. A four-dimensional model. Arch Gen Psychiatry 16:146–151
Pietzcker A, Gebhardt R, Strauss A, Stöckel M, Langer C, Freudenthal K (1983) The syndrome scales in the AMDP-system. Mod Probl Pharmacopsychiat, vol 20. Karger, Basel, pp 88–99
Pietzcker A, Gaebel W, Köpke W, Linden M, Müller P, Müller-Spahn F, Schüssler G, Tegeler J (1986) A German multicenter study on neuroleptic long-term therapy of schizophrenic patients. Preliminary report. Pharmacopsychiatry 19:161–166
Prasad AJ, Kumar N (1988) Suicidal behavior in hospitalized schizophrenics. Suicide Life-threat Behav 18:265–269
Prosser ES, Csernansky JG, Kaplan J, Thieman S, Becker TJ, Hollister LE (1987) Depression, Parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J Nerv Ment Dis 175:100–105
Prusoff BA, Williams DH, Weissman MM, Astrachan BM (1979) Treatment of secondary depression in schizophrenia. Arch Gen Psychiatry 36:569–575
Quitkin F, Rifkin A, Kane J, Romas-Lorenzi JR, Klein D (1978) Long-acting oral vs injectable antipsychotic drugs in schizophrenics. Arch Gen Psychiatry 35:889–892
Rifkin A, Quitkin F, Klein DF (1975) Akinesia. A poorly recognised drug-induced extrapyramidal behavioral disorder. Arch Gen Psychiatry 32:672–674
Roy A, (1987) Risk factors for depression in schizophrenia. American Psychiatric Association Annual Convention, Chicago, May 1987, pp 123–127
Salama AA (1988) Depression and suicide in schizophrenicients. Suicide Life-threat Behav 18:379–384
Sheldrick C, Jablensky A, Sartorius N, Shepherd M (1977) Schizophrenia succeeded by affective illness: catamnestic study and statistical enquiry. Psychol Med 7:619–624
Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand [Suppl] 212:11–19
Siris SG, Strahan A (1988) Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression. J Clin Psychiatry 49:439–440
Siris SG, Kammen DP van, Docherty JP (1978) Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 35: 1368–1377
Siris SG, Harmon GK, Endicott J (1981) Postpsychotic depressive syndromes in hospitalized schizophrenic patients. Arch Gen Psychiatry 38:1122–1123
Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB (1987) Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. Arch Gen Psychiatry 44:533–539
Siris G, Adan F, Cohen M, Mandeli J, Aronson A, Casey E (1988) Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 145:1532–1537
Siris SG, Sellew AP, Frechen K, Cooper TB, Mandell J, Casey E (1988) Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations. Clin Chem 35:837–840
Strauss JS, Carpenter WT (1972) The prediction of outcome in schizophrenia. Arch Gen Psychiatry 27:739–746
Strian F, Klicpera C (1983) Anxiety in schizophrenic patients. Arch Psychiatr Nervenkr 233:347–357
Tsuang MT, Woolson RF, Fleming JA (1980) Premature deaths in schizophrenia and affective disorders. Arch Gen Psychiatry 37:979–983
Van Kammen DP, Alexander PE, Bunney WE (1980) Lithium treatment in post-psychotic depression. Br J Psychiatr 136: 479–485
Van Putten T, May PRA (1978) ‘Akinetic depression’ in schizophrenia. Arch Gen Psychiatry 35:1101–1123
Von Zerssen D, Koeller DM (1976) Paranoid-Depressivitätsskala. Manual. Beltz, Munich
Weissman MM, Pottenger M, Kleber H, Ruben H, Williams D, Thompson WD (1977) Symptom pattern in primary and secondary depression. Arch Gen Psychiatry 34:854–862
Wistedt B (1984) 4-Jahres-Katamnesen bei behandelten und nicht behandelten chronisch schizophrenen Patienten in der Ambulanz. In: Kryspin-Exner K, Hinterhuber H, Schubert H (eds) Langzeittherapie psychiatrischer Erkrankungen. Schattauer, Stuttgart
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Bandelow, B., Müller, P., Gaebel, W. et al. Depressive syndromes in schizophrenic patients after discharge from hospital. Eur Arch Psychiatry Clin Nuerosci 240, 113–120 (1990). https://doi.org/10.1007/BF02189981
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02189981